Navigation Links
Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
Date:9/3/2008

udy arm conducted in 21 treatment-naive patients where the imiquimod application was omitted, did not show a significant reduction of the viral load. Thus the results strongly support the notion that the future co-administration of a TLR adjuvant, like IC31(R), is pivotal for the therapeutic effect of the vaccine.

"Our study is the first report to show significant long-term viral load effects of therapeutic vaccination. In particular the increasing RNA decline up to 6 months after vaccination is extremely encouraging and finally suggests the formulation of our vaccine with IC31(R), a strong TLR agonist. Furthermore our vaccine in future trials may be combined with standard therapy or novel antivirals." states Alexander von Gabain, Chief Scientific Officer of Intercell.

Although options for the treatment of chronic Hepatitis C with Interferon/Ribavirin have improved, treatment will remain very difficult and a significant unmet medical need, especially in the case of Genotype 1. Novel immunotherapies, and possibly therapeutic vaccines, might become an option in the arena of existing and future HCV combination treatments. Thus, Intercell will follow its development strategy that will also take advantage of an enlarged antigen portfolio and of IC31(R), Intercell's second-generation adjuvant that has recently demonstrated the generation of T-cell responses, in human vaccine trials, to a level not yet seen for other known adjuvants.

About Hepatitis C

HCV is a major cause of chronic liver disease, including cirrhosis and liver cancer. According to the World Health Organization (WHO), approximately 170 million people worldwide are chronic HCV carriers (3% of the world's population), including about 10 million Europeans, 3.9 million Americans and 2 million Japanese. 35,000 new infections occur in the United States alone each year. The substantial unmet medical need is underscored by the fact that each year 8,000 to 10,000 deaths and 1,000 liver tr
'/>"/>

SOURCE Intercell AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
2. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
3. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
4. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
5. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
6. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
7. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
8. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
9. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
10. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
11. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Intarcia Therapeutics, Inc. today announced ... recently announced synthetic royalty / equity convert financing, bringing ... purchased Convertible Limited Recourse Notes from Intarcia and are ... any future global net sales of ITCA 650 until ... have the option, commencing upon U.S. regulatory approval of ...
(Date:6/2/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... U.S. Food and Drug Administration (FDA) of its Abbreviated ... 5mg/5mL. Trailing twelve-month sales for the product are $30 ... expects to begin shipping to its customers shortly. ... of ANI Pharmaceuticals, stated, "This ANDA represents ANI,s first ...
(Date:6/2/2015)... 2, 2015  PROMETRIKA, LLC, a full-service clinical ... the addition of pharmacovigilance services for clinical trials.  ... safety data collection and reporting, as our service ... and expert physicians, each with more than 23 years ... monitoring of safety trends. ...
Breaking Medicine Technology:Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3PROMETRIKA Announces the Availability of Pharmacovigilance Services 2
... SAN DIEGO, July 9 Arena Pharmaceuticals, ... results from a multiple-ascending,dose Phase 1b clinical ... safety,pharmacokinetics and pharmacodynamics. APD791 is Arena,s internally,discovered ... of arterial,thrombosis and other related conditions., ...
... July 8 After meeting on July 1st ... new diabetes drugs should,undergo trials to rule out ... US endocrinologists agree with this recommendation, according to,AlphaDetail ... market,research and key opinion leader mapping solutions to ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2
(Date:6/2/2015)... Allred Dental, a dental office based in ... June-September, 2015 along with a $100 off with free oral ... , “Sometimes wisdom teeth can be impacted, meaning that they ... also only partially break through the gum, causing pain and ... in young people, as they do not have fully developed ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... "100K Factory" system was released to public yesterday, ... around the Internet. HonestyFirstReviews.com's senior product reviewer Tiffany ... posting a detailed review of the course on ... of training courses available for Internet marketers looking ...
(Date:6/2/2015)... 2015 MEDIA ADVISORY, June 2, ... , Email: ewallace(at)mentalhealthamerica(dot)net , Breaking News: Congressman Tim ... Legislation at MHA Annual Conference Thursday , Who: ... to address the Mental Health America Annual Conference ... version of the Helping Families in Mental Health ...
(Date:6/2/2015)... MI (PRWEB) June 02, 2015 On ... “Fighting Addiction Together” in the Hall of Legends at ... receiver and motivational speaker Herman Moore, the goal of ... of addiction in today’s society, highlight the benefits of ... inform the attendees about the options that are available ...
Breaking Medicine News(10 mins):Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2
... LOS ANGELES, Dec. 15 The holidays will be ... Southern California,s,largest children,s hospitals thanks to supermarket partners Ralphs ... The two supermarket chains announced today that they ... in communities served by their,stores in Southern California. The ...
... Dec. 15 The American Academy of,Dermatology (Academy) today issued ... to Congress about labeling information on the,relationship between the use ... skin damage. The FDA report was submitted pursuant to ... 2007. , "The American ...
... under age 65 were without health insurance for all or ... by the UCLA Center for Health Policy Research. ... California Health Interview Survey (CHIS), the policy brief,s authors found ... all or some of 2007, the most recent year for ...
... Aurora Health Care announced today that,the physicians of ... Wisconsin, have chosen to join Aurora Medical Group. , ... practice chiefly at Aurora hospitals and,clinics. , ... contribute to the quality,of the care we provide for Aurora ...
... from Medarex,s UltiMAb(R) technology platform - , ... (Nasdaq: MEDX ) today announced that it will ... in connection with the recently announced marketing approval from Health ... (ustekinumab, previously known as CNTO 1275) for ...
... lead people to choose salads over French fries? According to ... , people who choose from a large variety of menu ... who choose from shorter lists. , In a study that ... authors Aner Sela (Stanford University), Jonah Berger (University of Pennsylvania), ...
Cached Medicine News:Health News:Southern California Children's Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less 2Health News:American Academy of Dermatology Issues Statement on FDA Report to Congress About Labeling Information on Indoor Tanning Devices 2Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:Great Lakes Radiologists to Join Aurora Medical Group 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 3Health News:The virtue of variety: More options can lead to healthier choices 2
... a low-price PC-based, 2-8-channel system for ... the retina and the optic nerve. ... operator monitor, printer, keyboard, mouse, bioelectrical ... electrical connections are easily to install. ...
... tool that allows to see the fundus ... stimulated. Besides it also includes the refractive ... between the pupil picture and the fundus ... is especially suited for animal research and ...
5 mm...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
Medicine Products: